Approxima

Approxima is developing a novel treatment technology for patients with tricuspid regurgitation. The company's minimally invasive tricuspid valve repair system allows for the reshaping of the right ventricle to directly counteract right heart dilation, treating patients with tricuspid regurgitation. This enables medical professionals to implant the device into a patient’s heart during a beating-heart, minimally invasive procedure guided by medical imaging.